BPG is committed to discovery and dissemination of knowledge
Number of total visits
2730560
Number of visits today
322
Number of downloads
2001523
MEMBERSHIP
Cited by in F6Publishing
Number
Citing Articles
1
He MY, Yan FF, Cen KL, Shen P. Long survival after immunotherapy plus paclitaxel in advanced intrahepatic cholangiocarcinoma: A case report and review of literature. World J Clin Cases 2022; 10(32): 11889-11897 [DOI: 10.12998/wjcc.v10.i32.11889 ] [ Reference Citation Analysis ]
2
Yin C , Alqahtani A , Noel MS . The Next Frontier in Pancreatic Cancer: Targeting the Tumor Immune Milieu and Molecular Pathways. Cancers (Basel) 2022;14 :2619. [PMID: 35681599 DOI: 10.3390/cancers14112619 ] [ Cited by in Crossref: 2] [ Cited by in F6Publishing: 2 ] [ Article Influence: 2.0 ] [ Reference Citation Analysis ]
3
Yin C , Kulasekaran M , Roy T , Decker B , Alexander S , Margolis M , Jha RC , Kupfer GM , He AR . Homologous Recombination Repair in Biliary Tract Cancers: A Prime Target for PARP Inhibition? Cancers (Basel) 2022;14 :2561. [PMID: 35626165 DOI: 10.3390/cancers14102561 ] [ Cited by in Crossref: 2] [ Cited by in F6Publishing: 2 ] [ Article Influence: 2.0 ] [ Reference Citation Analysis ]
4
Gönül Geyik Ö , Anichini G, Ulukaya E, Marra F, Raggi C. DNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and Perspectives. Cells 2022;11 :1463. [DOI: 10.3390/cells11091463 ] [ Cited by in Crossref: 2] [ Cited by in F6Publishing: 1 ] [ Article Influence: 2.0 ] [ Reference Citation Analysis ]
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA California Corporate Number: 3537345
